Details for New Drug Application (NDA): 018689
✉ Email this page to a colleague
The generic ingredient in RIDAURA is auranofin. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the auranofin profile page.
Summary for 018689
Tradename: | RIDAURA |
Applicant: | Sebela Ireland Ltd |
Ingredient: | auranofin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018689
Suppliers and Packaging for NDA: 018689
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIDAURA | auranofin | CAPSULE;ORAL | 018689 | NDA | Sebela Pharmaceuticals Inc. | 54766-093 | 54766-093-06 | 60 CAPSULE in 1 BOTTLE (54766-093-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 3MG | ||||
Approval Date: | May 24, 1985 | TE: | RLD: | Yes |
Expired US Patents for NDA 018689
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 3,635,945 | ⤷ Subscribe |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 4,414,209 | ⤷ Subscribe |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 4,364,923 | ⤷ Subscribe |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 3,708,579 | ⤷ Subscribe |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | 4,225,597 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription